AKT1 and malignant colon neoplasm: Apigenin could suppress the m-TOR/PI3K/Akt signaling pathway to induce its anti-cancer potential in drug-resistant colon cancer cells, suggesting that apigenin could be a potential chemo-sensitizer to cisplatin in CRC cells [200].